We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pricing transparency is a key ingredient in bringing down prescription drug costs, according to a policy paper from the American College of Physicians. Read More
The FTC is suing Endo Pharmaceuticals and several other drugmakers over what it calls the illegal use of pay-for-delay settlements to block the market entry of generic forms of Opana ER and Lidoderm. Read More
Actavis received a setback in its quest to market a generic version of Lialda following a district court’s decision upholding Shire’s patent covering the ulcerative colitis drug. Read More
Japan’s Ministry of Health, Labour and Welfare has approved Biocon’s insulin glargine, the eighth biosimilar backed by the regulator since 2009. Read More
A federal jury ruled that Gilead Sciences must dole out $200 million in damages to Merck and Ionis Pharmaceuticals for patent infringement over the active ingredient sofosbuvir in Gilead’s blockbuster hepatitis C drugs. Read More